» Articles » PMID: 15578071

Lack of Association of Cytomegalovirus with Human Brain Tumors

Overview
Journal Mod Pathol
Specialty Pathology
Date 2004 Dec 4
PMID 15578071
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Cytomegalovirus (CMV) is thought to possess oncogenic properties and has been linked with a number of human malignancies. CMV infection was recently described in association with malignant gliomas. The intent of the present study was to further investigate the reported association between CMV and malignant gliomas. Tissue from 22 brain tumors of various histologic types and grades, four normal brains, six breast carcinomas, six colon carcinomas, six lung carcinomas, and six sarcomas were evaluated for the presence of CMV by polymerase chain reaction (PCR), in situ hybridization, and immunohistochemical methods. None of the brain tumors or normal brain tissue tested demonstrated evidence of CMV pp65 or early nuclear proteins by immunohistochemistry. In addition, no CMV RNA or DNA was detected in these cases by in situ hybridization and PCR. None of the carcinomas or sarcomas evaluated were positive for CMV by immunohistochemistry, in situ hybridization, or PCR. The findings of the present study suggest that CMV is not significantly associated with brain tumors in humans.

Citing Articles

Viruses in glioblastoma: an update on evidence and clinical trials.

Gunasegaran B, Ashley C, Marsh-Wakefield F, Guillemin G, Heng B BJC Rep. 2024; 2(1):33.

PMID: 39516641 PMC: 11524015. DOI: 10.1038/s44276-024-00051-z.


IMPACT OF NEUROTROPIC VIRUSES ON SURVIVAL OF PATIENTS WITH SURGICALLY TREATED GLIOBLASTOMA.

Koruga N, Pekmezovic T, Tomas I, Soldo Koruga A, Marjanovic K, Rajc J Acta Clin Croat. 2023; 61(3):476-481.

PMID: 37492371 PMC: 10364100. DOI: 10.20471/acc.2022.61.03.12.


Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments.

Ahn J, Shin C, Kim Y, Park J, Jeun S, Ahn S Brain Tumor Res Treat. 2022; 10(3):135-143.

PMID: 35929110 PMC: 9353163. DOI: 10.14791/btrt.2022.0010.


The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Daei Sorkhabi A, Sarkesh A, Saeedi H, Marofi F, Ghaebi M, Silvestris N Front Oncol. 2022; 12:818447.

PMID: 35515137 PMC: 9062077. DOI: 10.3389/fonc.2022.818447.


Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment.

Harrison M, Hochreiner E, Benjamin B, Lawler S, Zwezdaryk K Viruses. 2022; 14(1).

PMID: 35062307 PMC: 8777757. DOI: 10.3390/v14010103.